Wealth Enhancement Advisory Services’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
Wealth Enhancement Advisory Services's ORGO Position: Q3 2026 in Review
Wealth Enhancement Advisory Services reduced its Organogenesis Holdings (ORGO) stake by 40% in Q3 2026, selling an estimated $59K and leaving 45,616 shares worth $58.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4023.
Wealth Enhancement Advisory Services first reported a position in ORGO in Q3 2024 and has held it in 9 quarters since. The position peaked at $187K in Q1 2025. 118 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- Wealth Enhancement Advisory Services held 45,616 shares of Organogenesis Holdings worth $58.4K as of Q3 2026.
- Wealth Enhancement Advisory Services sold 30,041 Organogenesis Holdings shares in Q3 2026, an estimated $59K.
- Organogenesis Holdings made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #4023 holding.
- Wealth Enhancement Advisory Services first reported a position in Organogenesis Holdings in Q3 2024 and has held it in 9 quarters since.
- Wealth Enhancement Advisory Services's Organogenesis Holdings position peaked at $187K in Q1 2025.
- 118 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.